[Use of a gonadoliberin agonist with or without gonadoliberin pulses for ovulation induction in ovarian dystrophies]

J Gynecol Obstet Biol Reprod (Paris). 1995;24(4):362-7.
[Article in French]

Abstract

Objectives: Determine whether ovulation in dystrophic ovaries treated with GnRH agonist followed by GnRH pulses is due to the GnRH pulse or is patient-dependent. SITE. Endocrinology department, CHU Purpan, Toulouse, France.

Methods: Fifteen infertile patients, age range 22 to 35 years, with ovarian dystrophy were given GnRH agonist (Decapeptyl, 3.75 mg IM on day 3 of the cycle). In 5 patients, an IV pulse of GnRH was then given (6 micrograms/90 min).

Statistical analysis: Mann-Whitney U test, corrected chi 2 test.

Results: Ovulation was achieved in 8/15 cases (3/5 with and 5/10 without pulsatile GnRH p = NS) and 3 pregnancies (without pulsatile GnRH). Before treatment LH was higher in patients who had an ovulation.

Conclusion: Ovulation can be achieved after GnRH agonist treatment in patients with dystrophic ovaries, with or without pulsatile GnRH, particularly if the initial LH levels are high.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Drug Therapy, Combination
  • Female
  • Follicle Stimulating Hormone / blood
  • Gonadotropin-Releasing Hormone / therapeutic use*
  • Humans
  • Infusions, Intravenous
  • Injections, Intramuscular
  • Luteinizing Hormone / blood
  • Ovulation Induction / methods*
  • Polycystic Ovary Syndrome / blood
  • Polycystic Ovary Syndrome / drug therapy*
  • Pulsatile Flow
  • Treatment Outcome
  • Triptorelin Pamoate / therapeutic use*

Substances

  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone